Avivagen Financials
| VIVXF Stock | USD 0.0001 0.00 0.00% |
Avivagen |
Understanding current and past Avivagen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Avivagen's financial statements are interrelated, with each one affecting the others. For example, an increase in Avivagen's assets may result in an increase in income on the income statement.
Avivagen Stock Summary
Avivagen competes with Genomma Lab, Procyon, Hypera SA, and Cumberland Pharmaceuticals. Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada. Avivagen is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 100 Sussex Drive, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.avivagen.com |
| Phone | 613 702 2908 |
| Currency | USD - US Dollar |
Avivagen Key Financial Ratios
There are many critical financial ratios that Avivagen's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Avivagen reports annually and quarterly.Avivagen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avivagen's current stock value. Our valuation model uses many indicators to compare Avivagen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avivagen competition to find correlations between indicators driving Avivagen's intrinsic value. More Info.Avivagen is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avivagen's earnings, one of the primary drivers of an investment's value.Avivagen Systematic Risk
Avivagen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Avivagen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Avivagen correlated with the market. If Beta is less than 0 Avivagen generally moves in the opposite direction as compared to the market. If Avivagen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Avivagen is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Avivagen is generally in the same direction as the market. If Beta > 1 Avivagen moves generally in the same direction as, but more than the movement of the benchmark.
Avivagen November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Avivagen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avivagen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avivagen based on widely used predictive technical indicators. In general, we focus on analyzing Avivagen Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avivagen's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 97.22 |
Complementary Tools for Avivagen Pink Sheet analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |